Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 248

1.

Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis.

Mahlanza TD, Manieri MC, Klawiter EC, Solomon AJ, Lathi E, Ionete C, Berriosmorales I, Severson C, Stankiewicz J, Cabot A, Elkort M, Chitnis T, Bove R, Katz J, Houtchens M.

Mult Scler. 2020 Feb 17:1352458520904545. doi: 10.1177/1352458520904545. [Epub ahead of print]

PMID:
32065561
2.

Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials.

Ghezzi A, Chitnis T, K-Laflamme A, Meinert R, Häring DA, Pohl D.

Neurol Ther. 2020 Feb 14. doi: 10.1007/s40120-020-00178-4. [Epub ahead of print]

PMID:
32060877
3.

Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review.

Bartz D, Chitnis T, Kaiser UB, Rich-Edwards JW, Rexrode KM, Pennell PB, Goldstein JM, O'Neal MA, LeBoff M, Behn M, Seely EW, Joffe H, Manson JE.

JAMA Intern Med. 2020 Feb 10. doi: 10.1001/jamainternmed.2019.7194. [Epub ahead of print]

PMID:
32040165
4.

Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosis.

Glanz BI, Zurawski J, Gonzalez CT, Shamah R, Ratajska A, Chitnis T, Weiner HL, Healy BC.

Mult Scler Relat Disord. 2020 Jan 11;40:101944. doi: 10.1016/j.msard.2020.101944. [Epub ahead of print]

PMID:
32007653
5.

A roadmap to precision medicine for multiple sclerosis.

Chitnis T, Prat A.

Mult Scler. 2020 Jan 22:1352458519881558. doi: 10.1177/1352458519881558. [Epub ahead of print]

PMID:
31965904
6.

Association Between Cigarette Smoking and Multiple Sclerosis: A Review.

Rosso M, Chitnis T.

JAMA Neurol. 2019 Dec 16. doi: 10.1001/jamaneurol.2019.4271. [Epub ahead of print]

PMID:
31841592
7.

Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis.

Chitnis T, Glanz BI, Gonzalez C, Healy BC, Saraceno TJ, Sattarnezhad N, Diaz-Cruz C, Polgar-Turcsanyi M, Tummala S, Bakshi R, Bajaj VS, Ben-Shimol D, Bikhchandani N, Blocker AW, Burkart J, Cendrillon R, Cusack MP, Demiralp E, Jooste SK, Kharbouch A, Lee AA, Lehár J, Liu M, Mahadevan S, Murphy M, Norton LC, Parlikar TA, Pathak A, Shoeb A, Soderberg E, Stephens P, Stoertz AH, Thng F, Tumkur K, Wang H, Rhodes J, Rudick RA, Ransohoff RM, Phillips GA, Bruzik E, Marks WJ, Weiner HL, Snyder TM.

NPJ Digit Med. 2019 Dec 11;2:123. doi: 10.1038/s41746-019-0197-7. eCollection 2019.

8.

In Response to Letter to the Editor Regarding: A 10-Year Study of the Etiopathogenesis of Cysts With a Study of Seromucinous Glands in Vocal Folds.

Nerurkar NK, Chitnis T, Gupta VK, Muzumdar G, Patel K, Bhuiyan P.

Laryngoscope. 2019 Dec 4. doi: 10.1002/lary.28375. [Epub ahead of print] No abstract available.

PMID:
31800098
9.

Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline.

Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Charvet LE, Krupp LB.

Mult Scler. 2019 Nov 28:1352458519891984. doi: 10.1177/1352458519891984. [Epub ahead of print]

PMID:
31775571
10.

School performance and psychiatric morbidity 6 years after pediatric acute disseminated encephalomyelitis: A nationwide population-based cohort study.

Boesen MS, Langkilde A, Born AP, Magyari M, Blinkenberg M, Chitnis T, Thygesen LC, Eriksson F.

Mult Scler Relat Disord. 2019 Nov;36:101425. doi: 10.1016/j.msard.2019.101425. Epub 2019 Oct 3.

PMID:
31655433
11.

Pan-viral serology implicates enteroviruses in acute flaccid myelitis.

Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GA, Sample HA, Zorn KC, Banerji D, Khan LM, Bove R, Hauser SL, Gelfand AA, Johnson-Kerner BL, Nash K, Krishnamoorthy KS, Chitnis T, Ding JZ, McMillan HJ, Chiu CY, Briggs B, Glaser CA, Yen C, Chu V, Wadford DA, Dominguez SR, Ng TFF, Marine RL, Lopez AS, Nix WA, Soldatos A, Gorman MP, Benson L, Messacar K, Konopka-Anstadt JL, Oberste MS, DeRisi JL, Wilson MR.

Nat Med. 2019 Nov;25(11):1748-1752. doi: 10.1038/s41591-019-0613-1. Epub 2019 Oct 21.

PMID:
31636453
12.

Serum NFL levels should be used to monitor multiple sclerosis evolution - Commentary.

Chitnis T.

Mult Scler. 2020 Jan;26(1):21-22. doi: 10.1177/1352458519880471. Epub 2019 Oct 18. No abstract available.

PMID:
31625830
13.

History of fatigue in multiple sclerosis is associated with grey matter atrophy.

Palotai M, Nazeri A, Cavallari M, Healy BC, Glanz B, Gold SM, Weiner HL, Chitnis T, Guttmann CRG.

Sci Rep. 2019 Oct 14;9(1):14781. doi: 10.1038/s41598-019-51110-2.

14.

γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance.

Rezende RM, Nakagaki BN, Moreira TG, Lopes JR, Kuhn C, Tatematsu BK, Boulenouar S, Maghzi AH, Rubino S, Menezes GB, Chitnis T, Weiner HL.

J Immunol. 2019 Nov 15;203(10):2621-2629. doi: 10.4049/jimmunol.1900784. Epub 2019 Oct 2.

PMID:
31578268
15.

Adipokines are associated with pediatric multiple sclerosis risk and course.

Keyhanian K, Saxena S, Gombolay G, Healy BC, Misra M, Chitnis T.

Mult Scler Relat Disord. 2019 Nov;36:101384. doi: 10.1016/j.msard.2019.101384. Epub 2019 Sep 5.

PMID:
31550559
16.

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS.

Deiva K, Huppke P, Banwell B, Chitnis T, Gärtner J, Krupp L, Waubant E, Stites T, Pearce GL, Merschhemke M.

J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):58-66. doi: 10.1136/jnnp-2019-321124. Epub 2019 Aug 29.

17.

Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis.

Santoro JD, Filippakis A, Chitnis T.

Epilepsy Behav Rep. 2019 Jun 23;12:100326. doi: 10.1016/j.ebr.2019.100326. eCollection 2019.

18.

Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depression.

Palotai M, Cavallari M, Koubiyr I, Morales Pinzon A, Nazeri A, Healy BC, Glanz B, Weiner HL, Chitnis T, Guttmann CR.

Mult Scler. 2019 Aug 16:1352458519869185. doi: 10.1177/1352458519869185. [Epub ahead of print]

PMID:
31418637
19.

Rotating night shift work and risk of multiple sclerosis in the Nurses' Health Studies.

Papantoniou K, Massa J, Devore E, Munger KL, Chitnis T, Ascherio A, Schernhammer ES.

Occup Environ Med. 2019 Oct;76(10):733-738. doi: 10.1136/oemed-2019-106016. Epub 2019 Aug 12.

PMID:
31405910
20.

Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes.

Yano H, Gonzalez C, Healy BC, Glanz BI, Weiner HL, Chitnis T.

Mult Scler Relat Disord. 2019 Oct;35:119-127. doi: 10.1016/j.msard.2019.07.021. Epub 2019 Jul 25.

PMID:
31374460

Supplemental Content

Loading ...
Support Center